Viral infections in celiac disease: what should be considered for better management.
- Published in:
- 2024
- By:
- Publication type:
- Literature Review
Works in Clinical & Experimental Medicine, 2024, Vol 25, Issue 1
Results: 20
1
2
Cancer vaccines: an update on recent achievements and prospects for cancer therapy.
- Published in:
- 2024
- By:
- Publication type:
- Literature Review
3
CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistance.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01538-2
- By:
- Publication type:
- Article
4
The long-term survival outcome of sporadic bilateral renal cell carcinoma and optimization of surgical treatment: a large-scale population-based cohort study.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01535-5
- By:
- Publication type:
- Article
5
Impact of pan-cancer analysis of the exportins family on prognosis, the tumor microenvironment and its potential therapeutic efficacy.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01534-6
- By:
- Publication type:
- Article
6
Construction and validation of immunogenic cell death-related molecular clusters, signature, and immune landscape in pancreatic cancer.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01533-7
- By:
- Publication type:
- Article
7
Impact of hyperkalaemia on renin–angiotensin–aldosterone (RAAS) inhibitor reduction or withdrawal following hospitalisation.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01531-9
- By:
- Publication type:
- Article
8
Ex vivo evaluation of the effect of plasma-derived factor VIII/von Willebrand factor in patients with severe hemophilia A on emicizumab prophylaxis.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01528-4
- By:
- Publication type:
- Article
9
Prediction and analysis of the tumor invasiveness of pulmonary ground-glass nodules based on metabolomics.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01529-3
- By:
- Publication type:
- Article
10
CYB561 a potential prognostic biomarker for liver hepatocellular carcinoma.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01522-w
- By:
- Publication type:
- Article
11
FUS and METTL3 collaborate to regulate RNA maturation, preventing unfolded protein response and promoting gastric cancer progression.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01525-7
- By:
- Publication type:
- Article
12
Non-invasive early-stage cancer detection: current methods and future perspectives.
- Published in:
- 2024
- By:
- Publication type:
- Literature Review
13
The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01523-9
- By:
- Publication type:
- Article
14
Bispecific antibodies in clinical practice: Understanding recent advances and current place in cancer treatment landscape.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01520-y
- By:
- Publication type:
- Article
15
The prognostic implications and oncogenic role of NSUN5 in clear cell renal cell carcinoma.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01507-9
- By:
- Publication type:
- Article
16
Current biological implications and clinical relevance of metastatic circulating tumor cells.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01518-6
- By:
- Publication type:
- Article
17
Chronobiological disruptions: unravelling the interplay of shift work, circadian rhythms, and vascular health in the context of stroke risk.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01514-w
- By:
- Publication type:
- Article
18
Analysis of METTL14 expression in pancreatic cancer and adjacent tissues and its prognostic value for patient outcomes.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01506-w
- By:
- Publication type:
- Article
19
Tumor-immune hybrid cells evade the immune response and potentiate colorectal cancer metastasis through CTLA4.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01515-9
- By:
- Publication type:
- Article
20
Development and validation of a model for predicting who can benefit from multiple TACE in HCC patients.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01516-8
- By:
- Publication type:
- Article